DOCSLIB.ORG

Nuclear Receptor Regulation of a Luminal Breast

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Nuclear Receptor Regulation of a Luminal Breast NUCLEAR RECEPTOR REGULATION OF A LUMINAL BREAST CANCER STEM CELL POPULATION by LYNSEY MAE FETTIG B.A., University of North Dakota, 2009 B.S., University of Minnesota, 2011 A thesis submitted to the Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirements for the degree of Doctor of Philosophy Cancer Biology Program 2019 This thesis for the Doctor of Philosophy degree by Lynsey Mae Fettig has been approved for the Cancer Biology Program by Rebecca Schweppe, Chair David Bentley Peter Kabos Maranke Koster Diana Cittelly Jennifer Richer Carol A. Sartorius, Advisor Date: May 17, 2019 ii Fettig, Lynsey Mae (Ph.D., Cancer Biology) Nuclear Receptor Regulation of a Luminal Breast Cancer Stem Cell Population Thesis directed by Professor Carol A. Sartorius ABSTRACT Crosstalk between nuclear receptors is emerging as important in regulating breast cancer (BC) treatment response and progression. Estrogen receptor (ER), progesterone receptor (PR), and retinoic acid receptor (RARα) are all co-expressed in luminal subtype BCs that are generally associated with good prognosis. This is mainly due to the success of endocrine therapies targeting ER. However, eventual resistance to endocrine therapy is a long-standing clinical problem that affects ~30% of patients. About half of all luminal tumors contain subpopulations of ER negative cells that express cytokeratin 5 (CK5). CK5+ cells exhibit cancer stem cell (CSC) properties such as resistance to chemo- and endocrine therapies, and enhanced tumor initiating potential. In previous work we identified that progesterone (P4) expands the population of CK5+ BC cells and that retinoids block such expansion. Thus, we decided to investigate the mechanisms by which PR, RARα, and their cognate ligands regulate breast CSC activity, expression of the CK5 gene, and tumor growth. P4-expanded CK5+ cells were more tumorigenic than CK5− cells in vivo, and P4 treated BC cells formed larger mammospheres in vitro. Either silencing of CK5 via shRNA or co-treatment with retinoic acid (RA) abolished this P4 effect in mammospheres. Using promoter deletion constructs, we identified a region 1.1 kb upstream of the CK5 transcriptional start site (TSS) that is necessary for P4 activation. We next performed ChIP and found that P4 induces association of both PR and RARα with the CK5 promoter at two distinct sites: a distal site (~1.1 kb upstream of the TSS) containing a putative progesterone response element and a proximal site (~130 bp upstream of the TSS) near a known retinoic acid iii response element. RA blocked recruitment of RARα and other essential co-factors to the CK5 promoter. In ongoing studies, we are assessing genome-wide crosstalk between PR and RARα in BC cells using RNA-seq and ChIP-seq. Treatment of BC xenografts in vivo with a retinoid reduced the accumulation of CK5+ cells during estrogen depletion. This reduction, together with the inhibition of CK5+ cell expansion through RAR/PR crosstalk, may explain the efficacy of retinoids in prevention of some BC recurrences. The form and content of this abstract are approved. I recommend its publication. Approved: Carol A. Sartorius iv DEDICATION I wish to thank the incredible people I have met who have encouraged me and helped me get to this point in my life. In particular, my teachers Phil Johnson and Brad Bachmeier who fostered my love of learning and showed me that, even though I am not an artist, I can still think creatively. Also, Dr. Kirsten Nielsen, Dr. Annabell Oh, Dr. Douglas Yee, and Kelly LaPara, who all saw something in me that I did not know was there and stepped in to help guide me through the process of becoming a scientist. I would especially like to thank my mentor, Dr. Carol Sartorius, for taking a chance on me. Even though I came to you under unusual circumstances, you welcomed me into the lab. You have not only been supportive of my career and allowed me to explore science in my own way, you have created an environment where I have been allowed to grow as a person and find my confidence. I cannot thank you enough. I am immensely grateful for my lab mates and graduate school friends. If it were not for you, I would not have survived. I cannot imagine having a more supportive group of people by my side as we tried to find our paths through all of this. You helped me see the good sides and funny sides, and helped pull me through the hard parts. I will forever be thankful for each of our friendships. I would also like to thank my parents, Kevin and Colleen, and my sister, Annie. Never did you tell me there were things in this life that were beyond my reach; instead you helped me figure out ways to make them happen, regardless of how asinine they initially seemed. The times you have come to my rescue – literally and figuratively – are innumerable. You have been there every time I have asked, and many where I did not have to. Without you wonderful people I would crumble. v To my babies, Elliot and Wesley – you make life so much better on the hard days. I hope I can make you proud. Lastly, I wish to thank my husband, Jayden. You have an incredible talent for knowing how I need to be supported, whether it is letting me work by myself at home while you enjoy your time on the ski hill, celebrating with me when it has been a good day for science, or bringing home ice cream when it has in fact not been a good day for science. Our lives have changed so much since we started this adventure, but six years and two kids later I am so glad that you have been my partner through it all. Here’s to the next chapter in our life together. And I promise, no more school. Really. I’m done this time. vi ACKNOWLEDGEMENTS I wish to thank the University of Colorado Cancer Center Flow Cytometry Core, Biorepository Core, Genomics and Microarray Core, and Tissue Culture Core supported by P30CA046934 for their technical assistance and services. This work was supported by UL1 TR002535 via the Colorado Clinical and Translational Sciences Institute (LMF) and National Institutes of Health grants NIH F31 CA210519 (LMF) and NIH 2R01 CA140985 (CAS). For animal work, our IACUC approval number is #000160. vii TABLE OF CONTENTS CHAPTER I. INTRODUCTION ..................................................................................................................... 1 Breast Cancer Incidence, Subtypes, and Treatment ............................................................ 1 Cancer Stem Cells ............................................................................................................... 4 Cytokeratin Structure and Function .................................................................................... 6 Cytokeratins in Breast Cancer ............................................................................................ 9 Nuclear Receptors ............................................................................................................. 12 Estrogen Receptors ............................................................................................... 14 Estrogen in Cancer ................................................................................................ 14 Progesterone Receptors ......................................................................................... 15 Progesterone Receptor in Breast Cancer ............................................................... 16 Retinoic Acid Receptors ....................................................................................... 18 Retinoic Acid Receptors in Cancer ....................................................................... 19 Crosstalk Among Nuclear Receptors .................................................................... 20 Thesis Direction and Summary ......................................................................................... 21 II. MATERIALS AND METHODS .......................................................................................... 23 Cell Culture and shRNA ................................................................................................... 23 CK5 Promoter Deletion Constructs .................................................................................. 23 Luciferase Reporter Assay and siRNA ............................................................................. 23 Chromatin Immunoprecipitation Assay ............................................................................ 24 Mammosphere Formation Assay and Proliferation Assays .............................................. 24 Immunoblotting................................................................................................................. 25 viii Immunohistochemistry, Immunocytochemistry, and Proximity Ligation Assays ............ 25 Quantitative Reverse Transcription PCR and RNA-sequencing ...................................... 26 Limiting Dilution Analysis and Tumor Growth ............................................................... 26 Statistical Methods ............................................................................................................ 27 III. CYTOKERATIN 5 IS DIRECTLY REGULATED BY PROGESTERONE AND IS IMPORTANT IN MEDIATING PROGESTERONE-INDUCED CANCER STEM CELL PROPERTIES ............................................................................................................................. 29 Introduction ....................................................................................................................... 29 Results ..............................................................................................................................
Load more

Recommended publications
  • Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases
    Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Olivares, Ana Maria, Oscar Andrés Moreno-Ramos, and Neena B. Haider. 2015. “Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases.” Journal of Experimental Neuroscience 9 (Suppl 2): 93-121. doi:10.4137/JEN.S25480. http:// dx.doi.org/10.4137/JEN.S25480. Published Version doi:10.4137/JEN.S25480 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320246 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Journal name: Journal of Experimental Neuroscience Journal type: Review Year: 2015 Volume: 9(S2) Role of Nuclear Receptors in Central Nervous System Running head verso: Olivares et al Development and Associated Diseases Running head recto: Nuclear receptors development and associated diseases Supplementary Issue: Molecular and Cellular Mechanisms of Neurodegeneration Ana Maria Olivares1, Oscar Andrés Moreno-Ramos2 and Neena B. Haider1 1Department of Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA. 2Departamento de Ciencias Biológicas, Facultad de Ciencias, Universidad de los Andes, Bogotá, Colombia. ABSTRACT: The nuclear hormone receptor (NHR) superfamily is composed of a wide range of receptors involved in a myriad of important biological processes, including development, growth, metabolism, and maintenance.
    [Show full text]
  • Interplay Between P53 and Epigenetic Pathways in Cancer
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2016 Interplay Between P53 and Epigenetic Pathways in Cancer Jiajun Zhu University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Biology Commons, Cell Biology Commons, and the Molecular Biology Commons Recommended Citation Zhu, Jiajun, "Interplay Between P53 and Epigenetic Pathways in Cancer" (2016). Publicly Accessible Penn Dissertations. 2130. https://repository.upenn.edu/edissertations/2130 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2130 For more information, please contact [email protected]. Interplay Between P53 and Epigenetic Pathways in Cancer Abstract The human TP53 gene encodes the most potent tumor suppressor protein p53. More than half of all human cancers contain mutations in the TP53 gene, while the majority of the remaining cases involve other mechanisms to inactivate wild-type p53 function. In the first part of my dissertation research, I have explored the mechanism of suppressed wild-type p53 activity in teratocarcinoma. In the teratocarcinoma cell line NTera2, we show that wild-type p53 is mono-methylated at Lysine 370 and Lysine 382. These post-translational modifications contribute ot the compromised tumor suppressive activity of p53 despite a high level of wild-type protein in NTera2 cells. This study provides evidence for an epigenetic mechanism that cancer cells can exploit to inactivate p53 wild-type function. The paradigm provides insight into understanding the modes of p53 regulation, and can likely be applied to other cancer types with wild-type p53 proteins. On the other hand, cancers with TP53 mutations are mostly found to contain missense substitutions of the TP53 gene, resulting in expression of full length, but mutant forms of p53 that confer tumor-promoting “gain-of-function” (GOF) to cancer.
    [Show full text]
  • Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2013 Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3 Dan Feng University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Genetics Commons, and the Molecular Biology Commons Recommended Citation Feng, Dan, "Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3" (2013). Publicly Accessible Penn Dissertations. 633. https://repository.upenn.edu/edissertations/633 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/633 For more information, please contact [email protected]. Epigenomic and Transcriptional Regulation of Hepatic Metabolism by REV-ERB and Hdac3 Abstract Metabolic activities are regulated by the circadian clock, and disruption of the clock exacerbates metabolic diseases including obesity and diabetes. Transcriptomic studies in metabolic organs suggested that the circadian clock drives the circadian expression of important metabolic genes. Here we show that histone deacetylase 3 (HDAC3) is recruited to the mouse liver genome in a circadian manner. Histone acetylation is inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Diurnal recruitment of HDAC3 corresponds to the expression pattern of REV-ERBα, an important component of the circadian clock. REV-ERBα colocalizes with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erbα in mouse liver causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by REV-ERBα directs a circadian rhythm of histone acetylation and gene expression required for normal hepatic lipid homeostasis. In addition, we reported that the REV-ERBα paralog, REV- ERBβ also displays circadian binding similar to that of REV-ERBα.
    [Show full text]
  • Circadian Modulation of Genome-Wide Rxr Binding in Mouse Liver Tissue
    Unicentre CH-1015 Lausanne http://serval.unil.ch Year : 2019 CIRCADIAN MODULATION OF GENOME-WIDE RXR BINDING IN MOUSE LIVER TISSUE Trang Khanh Bao Trang Khanh Bao, 2019, CIRCADIAN MODULATION OF GENOME-WIDE RXR BINDING IN MOUSE LIVER TISSUE Originally published at : Thesis, University of Lausanne Posted at the University of Lausanne Open Archive http://serval.unil.ch Document URN : urn:nbn:ch:serval-BIB_C4CE7516215F0 Droits d’auteur L'Université de Lausanne attire expressément l'attention des utilisateurs sur le fait que tous les documents publiés dans l'Archive SERVAL sont protégés par le droit d'auteur, conformément à la loi fédérale sur le droit d'auteur et les droits voisins (LDA). A ce titre, il est indispensable d'obtenir le consentement préalable de l'auteur et/ou de l’éditeur avant toute utilisation d'une oeuvre ou d'une partie d'une oeuvre ne relevant pas d'une utilisation à des fins personnelles au sens de la LDA (art. 19, al. 1 lettre a). A défaut, tout contrevenant s'expose aux sanctions prévues par cette loi. Nous déclinons toute responsabilité en la matière. Copyright The University of Lausanne expressly draws the attention of users to the fact that all documents published in the SERVAL Archive are protected by copyright in accordance with federal law on copyright and similar rights (LDA). Accordingly it is indispensable to obtain prior consent from the author and/or publisher before any use of a work or part of a work for purposes other than personal use within the meaning of LDA (art. 19, para.
    [Show full text]
  • Retinoid-Induced Apoptosis in Normal and Neoplastic Tissues
    Cell Death and Differentiation (1998) 5, 11 ± 19 1998 Stockton Press All rights reserved 13509047/98 $12.00 Review Retinoid-induced apoptosis in normal and neoplastic tissues Laszlo Nagy1,3,4, Vilmos A. Thomazy1, Richard A. Heyman2 retinoic acid receptor (RAR), which belongs to the superfamily and Peter J.A. Davies1,3 of ligand-activated transcription factors (nuclear receptors) revolutionized our understanding as to how retinoids exert 1 Department of Pharmacology, University of Texas-Houston, Medical School, their pleiotropic effects (for reviews see Chambon (1996); Houston, Texas 77225 USA Mangelsdorf et al (1994)). Members of the nuclear receptor 2 Ligand Pharmaceuticals, San Diego, California, 92121 USA superfamily mediate the biological effects of many hormones, 3 Corresponding author: PJAD, tel: 713-500-7480; fax: 713-500-7455; vitamins and drugs (i.e. steroid hormones, thyroid hormones, e-mail: [email protected] 4 vitamin D, prostaglandin-J (PG-J ) and drugs that activate Present address for correspondence: The Salk Institute for Biological Studies, 2 2 Gene Expression Laboratory, La Jolla, California 92037; peroxisomal proliferation). There are two families of retinoid tel: (619) 453-4100 fax:(619) 455-1349; e-mail: [email protected] receptors, Retinoid X Receptors (RXRs) that bind 9-cis retinoic acid (9-cis RA) and Retinoic Acid Receptors (RARs) Received 18.8.97; revised 19.9.97; accepted 22.9.97 that bind both 9-cis RA and all-trans retinoic acid (ATRA) (for Edited by M. Piacentini reviews see Chambon 1996; Mangelsdorf et al, 1994)). Each of these receptor families includes at least three distinct genes, (RARa,b and g; RXRa,b and g) that through differential Abstract promoter usage and alternative splicing, give rise to a large number of distinct retinoid receptor proteins (for reviews see Vitamin A and its derivatives (collectively referred to as Chambon 1996; Mangelsdorf et al, 1994).
    [Show full text]
  • Retinoid X Receptor Is Necessary to Establish the S-Opsin Gradient In
    Retinoid X Receptor ␥ Is Necessary to Establish the S-opsin Gradient in Cone Photoreceptors of the Developing Mouse Retina Melanie R. Roberts,1,2 Anita Hendrickson,2 Christopher R. McGuire,2 and Thomas A. Reh2 PURPOSE. The retinoid X receptors (RXRs) are members of the tion, they also have demonstrated some isoform-specific family of ligand-dependent nuclear hormone receptors. One of functions. For example, RXR␣ heterodimerizes with retinoic these genes, RXR␥, is expressed in highly restricted regions of acid receptors (RARs) to regulate retinal growth and cardiac the developing central nervous system (CNS), including the development.4 retina. Although previous studies have localized RXR␥ to de- Although all three isoforms are expressed in the developing veloping cone photoreceptors in several species, its function nervous system, RXR␥ has the most restricted and develop- in these cells is unknown. A prior study showed that thyroid mentally regulated expression. It is expressed in the develop- hormone receptor ␤2 (TR␤2) is necessary to establish proper ing striatum, part of the tegmentum, the pituitary, the ventral cone patterning in mice by activating medium-wavelength (M) horns of the spinal cord,3,5 and the retina.6 RXR␥-null mice cone opsin and suppressing short-wavelength (S) cone opsin. show isoform-specific defects in both striatal and hippocampal Thyroid hormone receptors often regulate gene transcription function, although RXR␤ can partially compensate for the loss as heterodimeric complexes with RXRs. of RXR␥ in the striatum.2,7,8 RXR␥ has also been identified in 6,9,10 METHODS. To determine whether RXR␥ cooperates with TR␤2 the developing retina of Xenopus, chicks, and mice.
    [Show full text]
  • Multi-Omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome
    cancers Review Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome Myriem Boufraqech and Naris Nilubol * Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20817, USA; [email protected] * Correspondence: [email protected] Received: 13 November 2019; Accepted: 3 December 2019; Published: 10 December 2019 Abstract: Recent advances in high-throughput molecular and multi-omics technologies have improved our understanding of the molecular changes associated with thyroid cancer initiation and progression. The translation into clinical use based on molecular profiling of thyroid tumors has allowed a significant improvement in patient risk stratification and in the identification of targeted therapies, and thereby better personalized disease management and outcome. This review compiles the following: (1) the major molecular alterations of the genome, epigenome, transcriptome, proteome, and metabolome found in all subtypes of thyroid cancer, thus demonstrating the complexity of these tumors and (2) the great translational potential of multi-omics studies to improve patient outcome. Keywords: genomic; proteomic; methylation; microRNA; thyroid cancer 1. Introduction The incidence of thyroid cancer has been increasing by almost 300% in the past four decades with an estimated 54,000 patients diagnosed each year in the United States [1]. Thyroid cancer is the fifth most common cancer in women. Earlier data has suggested that the rising incidence of thyroid cancer has been due to the increased detection of small, commonly incidental, and subclinical papillary thyroid cancer (PTC) with indolent behavior [1–4], however, the more recent analysis of the Surveillance, Epidemiology, and End Results (SEER) cancer registry data has shown an increase in advanced-stage PTC and PTC larger than 5 cm which were believed to be clinically detectable or were symptomatic [5].
    [Show full text]
  • Similarities and Differences in the Transcriptional Control of Expression
    Similarities and differences in the transcriptional PNAS PLUS control of expression of the mouse TSLP gene in skin epidermis and intestinal epithelium Krishna Priya Gantia,b,c, Atish Mukherjia,b,c,1, Milan Surjita,b,c,d,1, Mei Lia,b, and Pierre Chambona,b,c,2 aInstitut de Génétique et de Biologie Moléculaire et Cellulaire (CNRS UMR7104, INSERM U964), Illkirch 67404, France; bUniversity of Strasbourg Institute for Advanced Study, F-67083 Strasbourg, France; cCollège de France, 75005 Paris, France; and dTranslational Health Science and Technology Institute, National Capital Region Biotech Science Cluster, Faridabad-121001, India Contributed by Pierre Chambon, December 20, 2016 (sent for review November 18, 2016; reviewed by Christophe Benoist, Didier Picard, and Filippo M. Rijli) We previously reported that selective ablation of the nuclear corepressor-bound unliganded RXR-α (or RXR-β)/VDR and receptors retinoid X receptor (RXR)-α and RXR-β in mouse epidermal RXR-α (or RXR-β)/RAR-γ heterodimers bound to VDR and keratinocytes (RXR-αβep−/−) or a topical application of active vitamin RAR response elements (VDRE and RARE, respectively). Thus, D3 (VD3) and/or all-trans retinoic acid (RA) on wild-type mouse skin RXR-α and RXR-β ablations, which release both heterodimers induces a human atopic dermatitis-like phenotype that is triggered from their DBS, might abolish repression and allow other pro- by an increased expression of the thymic stromal lymphopoietin moter-bound transcription factors (TFs) to stimulate TSLP tran- (TSLP) proinflammatory
    [Show full text]
  • Retinoid X Receptors: X-Ploring Their (Patho)Physiological Functions
    Cell Death and Differentiation (2004) 11, S126–S143 & 2004 Nature Publishing Group All rights reserved 1350-9047/04 $30.00 www.nature.com/cdd Review Retinoid X receptors: X-ploring their (patho)physiological functions A Szanto1, V Narkar2, Q Shen2, IP Uray2, PJA Davies2 and aspects of metabolism. The discovery of retinoid receptors L Nagy*,1 substantially contributed to understanding how these small, lipophilic molecules, most importantly retinoic acid (RA), exert 1 Department of Biochemistry and Molecular Biology, Research Center for their pleiotropic effects.1,2 Retinoid receptors belong to the Molecular Medicine, University of Debrecen, Medical and Health Science family of nuclear hormone receptors, which includes steroid Center, Nagyerdei krt. 98, Debrecen H-4012, Hungary 2 hormone, thyroid hormone and vitamin D receptors, various Department of Integrative Biology and Pharmacology, The University of Texas- orphan receptors and also receptors activated by intermediary Houston Medical School, Houston, TX, USA * Corresponding author: L Nagy, Department of Biochemistry and Molecular metabolites: for example, peroxisome proliferator-activated Biology, University of Debrecen, Medical and Health Science Center, receptor (PPAR) by fatty acids, liver X receptor (LXR) by Nagyerdei krt. 98, Debrecen H-4012, Hungary. Tel: þ 36-52-416432; cholesterol metabolites, farnesoid X receptor (FXR) by bile Fax: þ 36-52-314989; E-mail: [email protected] acids and pregnane X receptor (PXR) by xenobiotics.3,4 Members of this family function as ligand-activated
    [Show full text]
  • Translational Alterations of Retinoid Receptors, Their Binding Partners and The
    Translational alterations of retinoid receptors, their binding partners and the retinoid signalling pathway in schizophrenia brain and blood Shan-Yuan Tsai Submitted in total fulfilment of the requirements of the degree of Doctor of Philosophy School of Psychiatry Faculty of Medicine August 2018 Thesis/Dissertation Sheet Australia's Global University Surname/Family Name Tsai Given Name/s Shan-Yuan Abbreviation for degree as give in the University calendar PhD Faculty Faulty of Medicine School School of Psychiatry Translational alt�ations of retinoid receptors,their binding partners and the Thesis Tille retinoid signalling pathway in schizophrenia brain and blood Abstract350 words maximum: (PLEASE TYPE) Schizophrenia is a debilitating mentalillness characterised by positive, negative and cognitive symptoms. Epidemiological studies implicate vitamin D in the aetiologyof schizophrenia and protein studies show altered circulating levels of the ligand vitamin D and implicate relinoids in schizophrenia. However, the gene expressions of vitamin D and rebnoid receptors have not beenext ensively studied. In parallel, there is increasing interest in the role ofneuroinflammation in the aetiology and progressionof schizophrenia and both vitamin D and retJnoids (vitamin A andits derivatives) have known anti-inflammatory actions. My thesis aims to measure expressionof molecules involved in vitamin D andretino id signalling and determine 1heinfluence of elevated inflammatory markers on these molecules. My findings are obtained from two cohoris: a post
    [Show full text]
  • Micrornas and Orphan Nuclear Receptor GCNF As Novel Regulators of Human Neural Stem Cell Differentiation and Neuronal Subtype Specification
    MicroRNAs and orphan nuclear receptor GCNF as novel regulators of human neural stem cell differentiation and neuronal subtype specification DISSERTATION zur Erlangung des Doktorgrades (Dr. rer. nat.) der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn vorgelegt von Laura Stappert aus Andernach Bonn, 2014 Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn am Institut für Rekonstruktive Neurobiologie 1. Gutachter: Prof. Dr. Oliver Brüstle 2. Gutachter: Prof. Dr. Michael Hoch Tag der Mündlichen Prüfung: 19.08.2015 Erscheinungsjahr: 2015 SUMMARY MicroRNAs (miRNAs) are currently recognized as important regulators of neural development. However, given the large number of miRNA species in existence, our understanding of miRNA-based regulation during neurogenesis remains incomplete, in particular with regard to human neural development. Human pluripotent stem cell (hPSC)-based neural stem cells (NSCs) now offer the possibility to study the function of miRNAs in association with early human neuronal differentiation. Thus, the aim of this study was to analyze the impact of miRNAs and their downstream effectors on human neuronal differentiation and subtype specification using a specific population of long-term self-renewing neuroepithelial-like stem (lt-NES) cells. First, a miRNA profiling analysis was performed covering the progression from human embryonic stem cells to neurons with lt-NES cells as a stable intermediate. Subsequent functional analyses demonstrated that miR-153, miR-181a/a* and miR-324-5p/3p are able to promote neuronal differentiation of lt-NES cells, similar to the impact of the neuronal-associated miR-124 and miR-125b. In addition, miR-124, miR-125b and miR-181a/a* were found to modulate the neuronal subtype composition of differentiating lt-NES cells, and transfection with respective miRNA oligonucleotides induced differentiation towards a dopaminergic phenotype.
    [Show full text]
  • Topic 1.1 Nuclear Receptor Superfamily: Principles of Signaling*
    Pure Appl. Chem., Vol. 75, Nos. 11–12, pp. 1619–1664, 2003. © 2003 IUPAC Topic 1.1 Nuclear receptor superfamily: Principles of signaling* Pierre Germain1, Lucia Altucci2, William Bourguet3, Cecile Rochette-Egly1, and Hinrich Gronemeyer1,‡ 1IGBMC - B.P. 10142, F-67404 Illkirch Cedex, C.U. de Strasbourg, France; 2Dipartimento di Patologia Generale, Seconda Università di Napoli, Vico Luigi De Crecchio 7, I-80138 Napoli, Italia; 3CBS, CNRS U5048-INSERM U554, 15 av. C. Flahault, F-34039 Montpellier, France Abstract: Nuclear receptors (NRs) comprise a family of 49 members that share a common structural organization and act as ligand-inducible transcription factors with major (patho)physiological impact. For some NRs (“orphan receptors”), cognate ligands have not yet been identified or may not exist. The principles of DNA recognition and ligand binding are well understood from both biochemical and crystal structure analyses. The 3D structures of several DNA-binding domains (DBDs), in complexes with a variety of cognate response elements, and multiple ligand-binding domains (LBDs), in the absence (apoLBD) and pres- ence (holoLBD) of agonist, have been established and reveal canonical structural organiza- tion. Agonist binding induces a structural transition in the LBD whose most striking feature is the relocation of helix H12, which is required for establishing a coactivator complex, through interaction with members of the p160 family (SRC1, TIF2, AIB1) and/or the TRAP/DRIP complex. The p160-dependent coactivator complex is a multiprotein complex that comprises histone acetyltransferases (HATs), such as CBP, methyltransferases, such as CARM1, and other enzymes (SUMO ligase, etc.). The agonist-dependent recruitment of the HAT complex results in chromatin modification in the environment of the target gene pro- moters, which is requisite to, or may in some cases be sufficient for, transcription activation.
    [Show full text]